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ABSTRACT 26 
The aim of this study was to identity metabolites and transformation products (TPs) in 27 
chicken muscle from amoxicillin (AMX), cephapirin (PIR) and ceftiofur (TIO), which 28 
are antibiotics of the β-lactam family. Liquid chromatography coupled to quadrupole 29 
time-of-flight (QqTOF) mass spectrometry was utilized due to its high resolution, high 30 
mass accuracy and MS/MS capacity for elemental composition determination and 31 
structural elucidation. 32 
Amoxicilloic acid (AMA) and amoxicillin diketopiperazine (DKP) were found as 33 
transformation products from AMX. Desacetylcephapirin (DAC) was detected as a 34 
metabolite of PIR. Desfuroylceftiofur (DFC) and its conjugated compound with 35 
cysteine (DFC-S-Cys) were detected as a result of TIO in contact with chicken muscle 36 
tissue. The metabolites and transformation products were also monitored during the in 37 
vivo AMX treatment and slaughtering period. It was found that two days were enough 38 
to eliminate AMX and associated metabolites/transformation products after the end of 39 
administration. 40 
Keywords: Amoxicillin, cephapirin, ceftiofur, chicken muscle, quadrupole time-of-41 
flight mass spectrometry, β-lactams, metabolites, transformation products. 42 
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INTRODUCTION 44 
Penicillins and cephalosporins are β-lactamic antibiotics that are widely used in 
45 
veterinary medicine (for livestock farming and bovine milk production) to prevent and 
46 
treat bacterial infections (respiratory, urinary and skin infections). They can also be 
47 
illegally used as growth promoters. The improper use of antibiotics may result in 
48 
undesirable residues in edible animal tissues, which are a hazard for human health, 
49 
causing allergic reactions in some individuals and, more importantly, reducing the 
50 
efficacy of antibiotics to treat diseases, due to the occurrence of new strains of 
51 
antibiotic-resistant bacteria [1]. 
52 
In order to regulate the use of these substances, and ensure a high level of protection for 53 
human health, the European Union has laid down a set of policies and measures, 54 
including the establishment of maximum residue limits (MRLs) for these antibiotics in 55 
food. A list of permitted substances with MRLs, is available in Annex I of Commission 56 
Regulation 37/2010 [2-3]. In addition, EU Commission Decision 2002/657/EC [4] sets 57 
requirements about the performance of analytical methods for determining veterinary 58 
drug residues in food [1, 5-8]. 59 
However, this legislation generally does not include metabolites or transformation 60 
products (TPs) that may be formed by pH shock (from 1.2 in the stomach to 8.0 in the 61 
colon), temperature excursion, or interaction with biological substances. TPs need to be 62 
identified in order to understand the associated toxicity or harmful effects. 63 
Factors in sample treatment [5,9-13] that could affect the stability of antibiotics and lead 64 
to the formation of artificial degradation products may also need to be evaluated to 65 
avoid misleading results. Efforts need to be made to minimize degradation during 66 
sample preparation. 67 
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Liquid chromatography-mass spectrometry (LC-MS) instruments with high resolution 68 
and high accuracy, such as liquid chromatography coupled to quadrupole time-of-flight 69 
mass spectrometry (LC-QqTOF MS/MS), have been used for the identification or 70 
structural characterisation of unknown compounds associated with β-lactam antibiotics 71 
[5, 14-20]. 72 
In this report, we studied the effect of pH, temperature and incubation time on the 73 
formation of metabolites and TPs from amoxicillin, cephapirin and ceftiofur in chicken 74 
muscle. The metabolites and TPs formed in AMX-treated chicken were also 75 
investigated. Liquid chromatography coupled with electrospray quadrupole time-of-76 
flight mass spectrometry (LC-QqTOF MS/MS) was used. 77 
78 
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EXPERIMENTAL 79 
 80 
2.1. Reagents and materials 81 
Amoxicillin (AMX) was supplied by Sigma-Aldrich (St. Louis, MO, USA); cephapirin 82 
(PIR), ceftiofur (TIO) and piperacillin (PIP, internal standard, IS) were supplied by 83 
Fluka (Buchs, Switzerland). 84 
All reagents were of analytical grade. Merck (Darmstadt, Germany) supplied 85 
hydrochloric (HCl), acetic (HAc), dichloroacetic and formic (HFor) acids, acetonitrile 86 
(MeCN, MS grade), ammonium acetate, ammonia (NH3), potassium 87 
dihydrogenphosphate, methanol (MeOH) and sodium hydroxide. Ultrapure water was 88 
generated by a MilliQ system (Millipore, Billerica, MA, USA). 89 
The SPE cartridges used were ENV+ Isolute (3 cm3/ 200 mg) from Biotage AB 90 
(Uppsala, Sweden). 91 
We used 45 µm nylon microcon centrifugal filter membranes (Millipore) to filter the 92 
extracts before injection into the chromatographic system. 93 
 94 
2.2. Preparation of standard and working solutions 95 
Individual AMX, PIR, TIO and PIP (IS) stock solutions were prepared at a 96 
concentration of 100 µg mL-1 in MilliQ water. Individual working solution used to spike 97 
the chicken muscle sample was prepared by diluting the stock solution to a 98 
concentration of 30 µg mL-1. 99 
Buffers between pH 1.5 and 8 were prepared to make the antibiotic working solutions, 100 
in order to investigate the generation of TPs at various pH. pH 1.5 was obtained with 101 
0.1% dichloroacetic acid buffer adjusted with 0.1 M HCl, pH 2 and 2.5 buffers were 102 
made with 0.1% HFor adjusted with 0.1 M hydrochloric acid; pH 3.0 and 3.5 buffers 103 
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with 0.1 % HAc adjusted with 0.1 M HCl; pH 4.5 and 5.5 buffers were made with 0.1% 104 
HAc adjusted with 0.1 M NH3; pH 6.5 and 8.0 buffer were made with 10 mM 105 
ammonium acetate adjusted with 0.1 M NH3. 106 
We adjusted 50 mM phosphate solutions to pH 5.0 and 8.5 with 0.1 M sodium 107 
hydroxide. Aqueous/organic solution H2O:MeCN (9:91; v:v) and organic MeCN:MeOH 108 
(50:50; v:v) were also prepared. 109 
 110 
2.3. Biological samples 111 
Chicken muscle meat was purchased from retail markets in Barcelona (Spain). The meat 112 
was minced, homogenized and stored at -20 ºC until sample preparation. 113 
 114 
2.4. Instrumentation 115 
LC-QqTOF analysis was performed on an Agilent 1200 RRLC binary pump 116 
chromatographic system (Waldbronn, Germany) with an autosampler injector, a 117 
thermostatically controlled column compartment coupled with an hybrid quadrupole 118 
time-of-flight QSTAR Elite mass spectrometer from Applied Biosystems (Concord, 119 
Ontario, Canada).  120 
Chromatographic separation was achieved on a Luna C18 column (50 x 2.0 mm, 3 µm, 121 
100 Å) from Phenomenex (Torrance, CA, USA). 122 
SPE was carried out on a SUPELCO vacuum manifold, connected to a SUPELCO 123 
vacuum tank (Bellefone, PA, USA). 124 
Auxiliary apparatuses were: a CRISON 2002 potentiometer (± 0.1 mV) (Crison S.A., 125 
Barcelona, Spain) equipped with a CRISON 5203 combination pH electrode from Orion 126 
Research (Boston, MA, USA); a centrifuge 460R from Hettich Zentrifugen (Germany); 127 
and a TurboVap LV system from Caliper LifeSciences, with a stream of nitrogen 128 
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(Hopkinton, MA, USA). An analytical balance with a precision ±0.1 mg and a vortex-129 
mixer were also used. 130 
 131 
2.5. Procedures 132 
2.5.1. Preliminary stability studies 133 
The stability of AMX, PIR and TIO solutions at different pH and repeated freeze-134 
thawing cycles was tested. Stock solutions were diluted in each buffer solution (pH 135 
values from 1.5 to 8) to obtain 10 µg mL-1 and analysed after 1 and 3 freeze-thawing 136 
cycles. 137 
We also evaluated the stability of each antibiotic in aqueous/organic solutions 138 
(H2O:MeCN and MeCN:MeOH) used in the sample treatment, at three different 139 
temperatures; 25, 35 and 45ºC. 140 
The influence of pH and incubation time was studied at 4 residence times of 0.3 (20 141 
minutes), 6, 12 and 24 hours within the pH range of 1.5 and 8. 142 
2.5.2. Sample preparation procedures 143 
Spiked chicken muscle samples were prepared by mincing 4 g (± 0.1mg) of blank 144 
chicken muscle and mixing with the desired volume of individual working solution (30 145 
µg mL-1) of antibiotics to obtain a final concentration of 1000 µg kg-1 for AMX and 500 146 
µg kg-1 for PIR and TIO. 147 
For sample extraction, 2 mL of MilliQ water and 20 mL of MeCN were mixed with 4g 148 
of muscle sample. The mixture was then shaken for 2 min. followed by centrifugation at 149 
3500 rpm for 5 min.. The supernatant was evaporated in a TurboVap system at 35ºC to 150 
remove the organic solvent, followed by an SPE clean up. The ENV+ Isolute cartridge 151 
was first activated with 2 mL of MeOH, 2 mL of MilliQ water and 2 mL of 50 mM 152 
phosphate buffer at pH 5. The muscle extract was then loaded to the cartridge and 153 
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washed with 3 mL of hydrogenphosphate buffer (pH 5) and 1 mL of MilliQ water. The 154 
targeted analytes were eluted with 4 mL of MeCN:MeOH (50:50; v:v) and dried at 35ºC 155 
under nitrogen stream. The residue was then reconstituted in 200 µL of MilliQ water 156 
and stored at -80ºC, which was filtered prior to LC-MS injection. 157 
2.5.3. Chromatography conditions 158 
LC used a binary linear gradient elution at a flow rate of 0.3 mL min-1. Mobile phase A 
159 
was water containing 0.1% of HFor and mobile phase B was MeCN containing 0.1% of 
160 
HFor with the following elution profile: 0 to 2.5 min, 1% mobile phase B; 2.5 to 3.5 
161 
min, mobile phase B increased to 25% and held to 4.5 min; 4.5 to 5 min, mobile phase 
162 
B increased to 35% and held to 10 min.; 10 to 10.1 min, mobile phase B increased to 
163 
90%. The column temperature was 20 ºC and the injection volume was 20 µL. 164 
2.5.4. ESI-QqTOF system 165 
The instrument was calibrated daily with a standard solution of rennin (1 pmol µL-1) 166 
using characteristic ions m/z 879.9723 and 110.0713. Mass spectra were acquired over 167 
the m/z 100-1100 range at a scan rate of 1s per spectrum. The instrument provided a 168 
typical resolution of 10000 at m/z 879.9723. To further ensure the mass accuracy, 169 
continuous calibration was carried out with phthalate at m/z 391.2843 and 149.0233. 170 
The ESI-QqTOF parameters were optimized using AMX (3 mg L-1 in water), due to its 
171 
relatively lower response compared with that of PIR and TIO. The turbo ionspray 
172 
source worked in positive ion and full spectrum mode. The optimized parameters were 
173 
as follows: declustering potential (DP) 50 V, focusing potential (FP) 200 V, turbo 
174 
ionspray voltage 5500 V, Q1 transmission window 50.1% for m/z 80 and 49.9% for m/z 
175 
190, declustering potential 2 (DP2) 10 V, gas source 1 (GS1) 50 (arbitrary units), gas 
176 
source 2 (GS2) 50 (arbitrary units), curtain gas (CUR) 50 (arbitrary units), ion release 
177 
delay (IRD) 6 (arbitrary units), ion release width (IRW) 5 (arbitrary units) and 
178 
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temperature (TEM) 400ºC. A collision energy (CE) of 20 V was applied to obtain 
179 
MS/MS spectrum for the information dependant acquisition (IDA) and product ion scan 
180 
(PIS). 
181 
All the acquisition and data analyses were performed using Analyst QS version 2.0 182 
(Applied Biosystems, PE Sciex, Concord, Ontario, Canada). 183 
184 
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RESULTS AND DISCUSSION 185 
3.1. Stability of AMX, PIR and TIO in solution 186 
According to some reports, AMX has chemical stability issues [10,21-23]. In this 187 
investigation, the impacts of pH, freeze-thaw cycles, solvents and evaporation 188 
temperature on the stability of AMX, PIR and TIO was studied to provide guidance for 189 
sample treatment and give insights into the fate of these antibiotics in metabolic 190 
processes. 191 
 192 
- Effect of pH and freeze-thaw cycles 193 
Stability of the antibiotics was investigated within the pH range close to that of animal 194 
digestion. AMX was reported to show chemistry stability problems [10,21-23]. 195 
The solutions of individual AMX, PIR and TIO in buffer of pH between 1.5 and 8 at a 196 
concentration of 10 mg L-1 were used. Samples were frozen at -80ºC for 72 h and then 197 
thawed at room temperature for analysis. Figure 1 shows a total ion chromatogram of 198 
the AMX samples exhibiting different profiles depending on the pH. Figure 1 also 199 
depicts EICs of the molecular ions and MS/MS spectra. AMX became more stable in 200 
the least acidic condition. From pH 3 to 8, AMX remained stable (peak 1). The presence 201 
of m/z 349.0869 that corresponded to a loss of ammonia and a product ion at m/z 202 
160.0426 corresponding to subsequent cleavage is common for AMX and other β-203 
lactam antibiotics [24-26]. However, at pH 1.5, AMX was totally degraded to AMX-1 204 
(peak 2) with an ion at m/z 384.1224 ([M+H]+, [C16H22N3O6S]+). Losses of ammonia, 205 
and CO2 from the protonated molecular ion produced ions at m/z 367.0968 and 206 
340.1330. This suggests that AMX-1 has a structure of amoxycilloic acid (AMA) [25-207 
27]. The presence of four chromatographic peaks with the same mass ion of 384.1224 208 
indicates the possible formation of stereoisomers. However, only two of them, AMA 209 
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(5S,6R and 5R,6R), were reported [25-27]. At pH 2, AMX was only partially converted 210 
to AMA, which also contains stereoisomers but with a different distribution, possibly 211 
due to the impact of pH. Only a low level of AMA was formed at pH 2.5. The MS/MS 212 
fragment ions observed are listed in Table 1. AMX was also found to react with buffer 213 
components (formic acid, acetic acid and NH3) to form different adducts that exhibit 214 
chromatographic peaks at different retention times (peaks 3, 4 and 5) with MS ions at 215 
m/z 412.1197, 426.1304 and 383.1400 respectively. MS/MS losses of HCOOH, 216 
CH3COOH and NH3 revealed that they are the corresponding adducts. 217 
LC-MS chromatograms of PIR samples (Figure 2) revealed that PIR is also unstable in 218 
acidic media. In the pH range of 1.5 to 2, PIR-1 was observed with an ion at m/z 219 
364.0249 ([M+H]+, [C15H14N3O4S2]+) as a TP (Table 1), which is m/z 60 units less than 220 
the m/z of PIR. This indicates that PIR-1 may be generated from PIR by loss of the 221 
lateral chain. The MS/MS ions of PIR-1 at m/z 226.0255, 152.0175 and 112.0235 are 222 
consistent with a low resolution MS/MS, previously described for cephapirin lactone 223 
(PLA) in bovine milk [28]. At pH 3 and above, PIR remained stable. 224 
TIO seems to be the most stable one among the three antibiotics studied within the pH 225 
range tested. TIO exhibits ions at m/z at 524.0354 ([M+H]+) and 241.0408, which 226 
corresponds to the fragmentation of the β-lactam ring. At pH 8, TIO-1, a minor 227 
degradation product, was observed with an ion at m/z 430.0322 ([C14H16N5O5S3]+) and 228 
an MS/MS fragmentation ion at m/z 241.0410, which is attributed to fragmentation of 229 
the β-lactam ring of the parent compound. The mass spectrum for TIO-1 matched 230 
desfuroylceftiofur (DFC), which has been obtained in milk [29]. 231 
Table 1 shows the parent compounds (AMX, PIR and TIO), TPs, molecular ions and 232 
fragmentation ions observed in IDA mode, and the pH at which the TPs were formed. 233 
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The number of freeze-thaw cycles could also affect the stability of the antibiotics. Three 234 
freeze-thaw cycles were carried out on the antibiotic buffer solutions of different pH. 235 
The chromatograms of AMX at pH 1.5 show five peaks of TPs. MS/MS showed that 236 
three are AMA stereoisomers, while the other two are new transformation product 237 
isomers of AMX-2, which exhibited ion at m/z 340.1338 ([M+H]+, [C15H22N3O4S]+). 238 
MS/MS ions were found at m/z 323.1076 corresponding to the loss of NH3, m/z 239 
189.0706 via fragmentation of the amide group, and m/z 160.0433 generated by the 240 
cleavage of the five membered thiazolidine ring from the molecular ion. This suggests 241 
that AMX-2 matches the structure of amoxicillin penilloic acid (AMP) [26]. The results 242 
are shown in Table 1. 243 
After three freeze-thaw cycles, PIR generated more new TPs: PIR-2, PIR-3 and PIR-4, 244 
in addition to PLA. The LC-MS chromatograms are presented in Figure 2. PIR-2 was 245 
observed in the whole pH range with an ion at m/z 382.0539 ([M+H]+, 246 
[C15H16N3O5S2]+). MS/MS fragmentation of the ion of [M+H]+ gave the product ions as 247 
shown in Table 1. The MS/MS spectrum and fragmentation pathway are presented in 248 
Figure 3A. PIR-2 matched the structure of desacetylcephapirin (DAC). PIR-3 was also 249 
observed in the whole pH range, with an ion at m/z 366.0584 ([M+H]+, 250 
[C15H16N3O4S2]+). MS/MS fragmentation ions are shown in Table 1. The ion at m/z 251 
209.0335 is generated by cleavage of the β-lactam group, while cleavage of the β-252 
lactam and the six-membered ring gave ions at m/z 253.0136. The loss of CO from the 253 
ion at m/z 253.0136 produced the ion at m/z 226.0247. PIR-3 has the structure of 254 
dihydrogenated PLA (diH-PLA). PIR-4 only appeared at pH below 3. PIR-4 has the 255 
same molecular ion as that of PIR-2, but a different mass spectral pattern (Figure 3). 256 
MS/MS spectra of PIR-4 are shown in Figure 3B, with a proposed structure that 257 
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matches that of hydrolysed PLA (Hydro-PLA). No new TPs were observed from TIO 258 
after three freeze-thaw cycles. 259 
 260 
-Effect of solvents and evaporation temperature 261 
We used a procedure reported in literature [30] with the mixture of MeCN:H2O and 262 
MeCN:MeOH to extract the antibiotics from biomatrix. Accordingly, stability of the 263 
antibiotics in MeCN:MeOH (50:50; v:v) and H2O:MeCN (9:91;v:v) were evaluated 264 
with evaporation temperatures of 25, 35 and 45ºC. MeCN:MeOH (50:50; v:v) at 35ºC 265 
was found to be the best combination. In H2O:MeCN (9:91;v:v) especially at higher 266 
evaporation temperature, AMX showed degradation. In addition to AMA, another 267 
degradation product AMX-3 was detected with m/z at 366.1143 ([M+H]+, 268 
[C16H20N3O5S]+) . The MS/MS ions are shown in Table 1. The ions at m/z 207.0783 and 269 
160.0447 correspond to fragments via cleavage of the five-membered thiazolidine ring. 270 
AMX-3 matched the structure of amoxicillin diketopiperazine (DKP). Figure 4A shows 271 
the abundance of AMX and its TPs at various temperatures. AMX decreased while 272 
AMA and DKP increased especially at high temperatures. Figure 4B shows the 273 
abundance of PIR and DAC at the evaluated temperatures. Formation of DAC was 274 
observed. However, the level of DAC did not change substantially by increasing the 275 
temperature, although the PIR signal decreased significantly, which may be due to other 276 
unknown side reactions. 277 
Figure 4C shows the change in abundance of TIO. Although the TIO signal decreased at 278 
higher temperatures no TPs were detected. 279 
The degradation of antibiotics may explain the low recovery values reported in the 280 
literature for the determination of AMX and PIR in food of animal origin [9,30]. In this 281 
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investigation, 35 ºC was selected as the most suitable extract evaporation temperature, 282 
to decrease the evaporation time without significant degradation of the antibiotics. 283 
 284 
3.2. Optimisation on biological samples 285 
- Impact of the pH of SPE eluent on recovery 286 
The pH of the SPE eluent had a significant impact on the recovery of the antibiotics, 287 
particularly AMX, which had a recovery of 13% at pH 8.5, but 46% at pH 5.0. At pH 288 
5.0, PIR and TIO had recoveries of 94% and 72%, respectively. Accordingly, we 289 
selected a pH of 5.0 for the eluent, which was adjusted using phosphate buffer for the 290 
biological sample analysis. 291 
 292 
- Effect of pH and incubation time on stability 293 
The effect of pH and the incubation time of the antibiotics with the chicken muscle 294 
matrix was studied. Four pH (1.5, 2.0, 6.5, 8.0) with four incubation time points (0.3, 6, 295 
12, 24 hr) were evaluated. For AMX during an incubation time of 6 hr or less at all of 296 
pH tested, only a low level of DKP was detected, along with AMX as a major peak. 297 
Neither AMP nor AMA were detected under these conditions. A slight splitting of the 298 
AMX EIC peak was observed, possibly due to a slow kinetic isomerisation process. 299 
After 12 hr, the intensity of the AMX peak decreased, with no further increase in DKP. 300 
After 24 hr, AMX completely disappeared. AMA and AMP were not observed, while a 301 
new compound (AMX-4) was detected with m/z at 252.1224 ([M+H]+, Table 1). The 302 
concentration changes of AMX and AMX-4 with incubation time at pH 2 are shown in 303 
Figure 5A. Similar behaviour was also observed at pH 1.5, 6.5 and 8. The structure of 304 
AMX-4 remains to be determined. 305 
 15
PIR became much less stable when it was incubated with chicken muscle. Even at 0.3 306 
hr, a high level of DAC was detected as the most abundant compound in all samples, 307 
independent of pH. DAC was observed as a result of interaction between PIR and 308 
solvents, but incubation with chicken muscle facilitated its formation. Splitting in the 309 
DAC peak that increased with time indicated potential isomerisation. PLA or its 310 
derivatives Hydro-PLA and diH-PLA were not observed. At 6 hr or more, PIR 311 
disappeared in almost all samples with DAC as the principal species. No new TPs were 312 
detected. 313 
TIO is the most stable of the three antibiotics. However, the incubation of TIO with 314 
chicken muscle tissue facilitated the formation of DFC. Figure 5B shows the 315 
concentration change of TIO with time at pH 8. At 0.3 hr, a low level of DFC was 316 
detected. At 6 hr, the level of TIO decreased with a concomitant increase in DFC. 317 
However, at 12 hr TIO still decreased, but DFC was lower too. A new compound, TIO-318 
2, with an ion at m/z 549.0314 ([M+H]+, [C17H20O7N6S4]+) was detected in all of the 319 
samples. The change of TIO-2 over time is presented in Figure 5B. At 24 hr, both TIO 320 
and TIO-2 decreased while DFC showed a constant level. Similar phenomena were 321 
observed at all of the pH tested. This suggests that TIO-2 may be an adduct of DFC 322 
with cysteine (DFC-S-Cys), which is still a TP of TIO. The suggested structure of TIO-323 
2 is shown in Table 1, where the associated mass errors were below 5 ppm in all 324 
compounds, except for AMX-3 and TIO-2, in which the errors were slightly higher, 325 
possibly due to the low concentration. 326 
 327 
3.3. Application to treated chicken 328 
The established methodology was applied to the analysis of muscle samples from 329 
chickens that had been treated with AMX. The treatment involved a daily dose of 14 mg 330 
 16
kg-1 for 4 days. The chickens were slaughtered on the third day of treatment and 48 hr 331 
after the 4 day treatment. The muscle samples were obtained and stored at -80ºC prior to 332 
analysis. Blank control samples were obtained from untreated chicken. AMX was 333 
detected in the 3 day samples, but not AMA or DKP. A new compound was detected, 334 
AMX-5, with an ion m/z 209.0932 ([M+H]+, [C10H13O3N2]+). The MS/MS fragment ion 335 
at m/z 192.0663 may be due to the loss of NH3. AMX-5 matched the structure of 336 
amoxicillin aldehyde (AMX-ALD), as presented in Table 1. In the samples taken 48 hr 337 
after 4 day treatment, none of the AMX, other metabolites or TPs were detected. This 338 
indicates that 48 hr after the end of AMX treatment was long enough to metabolize and 339 
eliminate administered AMX. After storage for 10 months at -80ºC, no AMX or TPs 340 
were detected in any of samples, including the three day samples. 341 
342 
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CONCLUSIONS 343 
Solution stability studies with a pH range between 1.5 and 8.0 revealed that AMX and PIR 344 
are unstable in strongly acidic media, whereas TIO only suffered a partial degradation at 345 
pH 8. AMA, PLA and DFC were the main TPs from AMX, PIR and TIO respectively. 346 
New TPs were observed after multi-freeze-thaw cycles of the solutions containing the 347 
antibiotics, including AMP from AMX and DAC, diH-PLA and Hydro-PLA from PIR. 348 
Incubation of AMX, PIR, and TIO with chicken muscle matrix for different times (0.3 hr, 349 
6 hr, 12 hr and 24 hr) at different pH (1.5, 2.0, 6.5 and 8.0) were performed. DKP, AMX-4, 350 
DAC, DFC, and an adduct of DFC with cysteine were observed as TPs. In the muscle 351 
samples from chicken treated in vivo with AMX for 4 days, AMX-ALD was observed as a 352 
new TP. No AMX residues or any TPs were detected in the samples 48 hr after AMX 353 
treatment. 354 
 355 
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FIGURE CAPTIONS 468 
 469 
Figure 1. Effect of pH on the formation of transformation products of AMOX. EIC and 470 
MS/MS spectra of the observed compounds. 471 
 472 
Figure 2. Effect of pH and freeze-thaw cycles on the formation of transformation 473 
products of PIR. EIC and MS/MS spectra of the observed compounds. 474 
 475 
Figure 3.Comparison between the mass spectra fragmentation pattern of PIR-2 and PIR-476 
4. 477 
 478 
Figure 4. Effect of aqueous/organic mixture H2O:MeCN (9:91;v:v) and temperature on 479 
A) AMX, B) PIR, C) TIO and the corresponding TPs. 480 
 481 
Figure 5. Effect of the contact time between antibiotics and matrix on the formation of 482 
TPs. A) AMX at pH 2. B) TIO at pH 8. 483 
Symbols: 484 
AMX AMX-4 TIO DFC TIO-2 
 485 
 486 
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  Table 1. Transformation products and metabolites found in pH, freeze-thaw (f-t) and biological sample studies.  
 
 
Compound Conditions [M+H]
+
 
exp Fragments Suggested structure 
Suggested 
namea 
[M+H]+ 
theo 
Error 
(ppm) 
AMX pH 1.5-8.0 366.1134 
[C16H20N3O5S]+ 
349.0869 
[C16H17N2O5S]+ 
208.0853 
[C10H12N2O3]+ 
160.0426 
[C6H10NO2S]+ 
HO
H
N
NH3
O
N
S
O
O
OH
CH3
CH3
 
 
AMX 366.1118 4.3 
AMX-1 pH 1.5-2.5 384.1222 
[C16H22N3O6S]+ 
367.0968 
[C16H19N2O6S]+ 
340.1330 
[C15H22N3O4S]+ 
323.1075 
[C15H19N2O4S]+ 
189.0692 
[C7H13N2O2S]+ 
160.0427 
[C6H10NO2S]+ 
HO
H
N
NH3
O
HN
S
O
OH
CH3
CH3
O
OH
 
AMA 384.1224 -0.5 
AMX-2 pH 1.5 
3 f-t cycles 
340.1338 
[C15H22N3O4S]+ 
323.1076 
[C15H19N2O4S]+ 
235.0755 
[C8H15N2O4S]+ 
189.0706 
C7H13N2O2S]+ 
160.0433 
[C6H10NO2S]+ 
HO
H
N
NH3
O
S
HN
O
OH
CH3
CH3
 
AMP 340.1326 +3.5 
AMX-3 Aqueous-
organic 
solvent- 
 
Contact 
with 
biological 
matrix 
366.1143 
[C16H20N3O5S]+ 
207.0783 
[C10H11N2O3]+ 
160.0447 
[C6H10NO2S]+ 
 
 
 
 
 
 
 DKP 366.1118 +6.8 
AMX-4 Contact 
with 
biological 
matrix  
252.1224 206.1171 
135.0677 
 
n.a. n.a. n.a. n.a. 
AMX-5 Treated 
chicken 
 209.0932 
[C10H13O3N2]+ 
192.0663 
[C10H10O3N]+ 
   
 
HO 
H 
N 
NH3 
O 
O 
H 
 
AMX-
ALD 
209.0921 +5.4 
PIR pH 1.5-8.0 424.0639 
[C17H18N3O6S2]+ 
364.0422 
[C15H14N3O4S2]+ 
320.0530 
[C14H14N3O2S2]+ 
292.0591 
[C13H14N3OS2]+ 
 
 
N
S
N
H2
O N
S
O
OHO
O CH3
O
 
PIR 424.0632 +1.7 
PIR-1 pH 1.5-2.0 364.0249 
[C15H14N3O4S2]+ 
226.0255 
[C9H10N2OS2]+· 
152.0175 
[C7H6NOS]+ 
112.0235 
[C5H6NS]+ 
N
S
N
H2
O N
S
O
O
O
 
 
PLA 364.0420 +2.4 
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Compound Conditions [M+H]
+
 
exp Fragments Suggested structure 
Suggested 
namea 
[M+H]+ 
theo 
Error 
(ppm) 
PIR-2 pH 1.5-8.0 
3 f-t cycles- 
Contact 
time with 
biological 
matrix 
382.0539 
[C15H16N3O5S2]+ 
364.0271 
[C15H14N3O4S2]+ 
320.0486 
[C14H14N3O2S2]+ 
292.0578 
[C13H14N3OS2]+ 
253.0087 
[C10H9N2O2S2]+ 
226.0235 
[C9H10N2OS2]+ 
152.0157 
[C7H6NOS]+ 
112.0227 
[C5H6NS]+ 
N
S
N
H2
O N
S
O
OHO
OH
 
DAC 382.0526 +3.4 
PIR-3 pH 1.5-8.0 
3 f-t cycles 
366.0584 
[C15H16N3O4S2]+ 
253.0136 
[C10H9N2O2S2]+ 
226.0247 
[C9H10N2OS2]+ 
209.0335 
[C9H9N2O2S]+ 
152.0176 
[C7H6NOS]+ 
112.0228 
[C5H6NS]+ 
N
S
N
H2
O N
S
O
O
HO
 
diH-PLA 366.0577 +1.9 
PIR-4 pH 1.5-2.5 
3 f-t cycles 
382.0546 
[C15H16N3O5S2]+ 
338.0657 
[C14H16N3O3S2]+ 
294.0548 
[C12H12N3O4S]+ 
227.0358 
[C9H11N2O3S]+ 
152.0183 
[C7H6NOS]+ 
126.0381 
[C6H8NS]+ 
112.0239 
[C5H6NS]+ 
N
S
N
H2
S
H
N
O
O O
O OH
 
Hydro-
PLA 
382.0526 +5.2 
TIO pH 1.5-8.0 
3 f-t cycles 
524.0354 
[C19H18N5O7S3]+ 
241.0408 
[C8H9N4O3S]+ 
N
SH3N
HN
O
NO
H3C
N
S
O
S
OH
O
O
O
 
 
TIO 524.0363 -1.7 
TIO-1 pH 8.0- 
Contact 
with 
biological 
matrix 
430.0322 
[C14H16N5O5S3]+ 
241.0410 
[C8H9N4O3S]+ 
N
SH3N
HN
O
NO
H3C
N
S
O
SH
OH
O
 
DFC 430.0308 +3.2 
TIO-2 Contact 
with 
biological 
matrix 
549.0314 
[C17H21N6O7S4] 
n.a. 
 
 
 
 
 
 
 
 
 
 
DFC-S-
Cys 
549.0349 -6.4 
 
(a) Key names: AMX, Amoxicillin; AMA, Amoxicilloic acid; AMP, Amoxicillin penilloic acid; DKP, Amoxicillin 
diketopiperazine; AMX-ALD, Amoxicillin aldehyde; PIR, Cephapirin; PLA, Cephapirin lactone; DAC, Desacetilcephapirin; diH-
PLA, Hidrogenated cephapirin lactone; Hydro-PLA, Hydrolized cephapirin lactone; TIO, Ceftiofur; DFC, Desfuroylceftiofur; 
DFC-S-Cys, Desfuroylceftiofur-S-cysteine; n.a., non-assigned. 
 
 





